Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE ABILITY OF TYRAMINE TO LIBERATE CATECHOLAMINES IN VIVO

N. Weiner, P. R. Draskóczy and W. R. Burack
Journal of Pharmacology and Experimental Therapeutics July 1962, 137 (1) 47-55;
N. Weiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. R. Draskóczy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. R. Burack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In anesthetized, atropinized dogs, intravenous nicotine produces a marked rise in the catecholamine output from the adrenal gland. Tyramine, in doses which produce a blood pressure response equal to or greater than that caused by nicotine, does not cause the liberation of catecholamines into adrenal venous blood. After adrenalectomy, nicotine administration leads to a rise in arterial plasma catecholamines, predominantly norepinephrine, which is simultaneous with the blood pressure effect. Tyramine only occasionally produces slight elevations in plasma catecholamines in adrenalectomized dogs. In adrenalectomized dogs pretreated with phenoxybenzamine, tyramine administration causes an increase in plasma catecholamine levels more frequently. However, the peak of the catecholamine rise occurs after the time when the maximal blood pressure response would be expected in dogs not pretreated.

Rats given large doses of tyramine have lower levels of heart, spleen and brown fat catecholamines than salinenjected controls. This depletion is maximal in spleen and brown fat after 5 minutes. After 30 minutes, only the heart becomes further depleted.

It is postulated that nicotine liberates catecholamines from nerve terminals, and from chromaffin granules of the adrenal medulla and from those associated with sympathetic nerves. Tyramine depletes a third compartment, in which circulating catecholamines are bound, and which is the site of uptake of exogenous catecholamines. Tyramine does not deplete chromaffin granules directly, although it may do so indirectly, as the granules lose catecholamines at an accelerated rate to replenish other stores.

Footnotes

    • Received February 23, 1962.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 137, Issue 1
1 Jul 1962
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE ABILITY OF TYRAMINE TO LIBERATE CATECHOLAMINES IN VIVO
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE ABILITY OF TYRAMINE TO LIBERATE CATECHOLAMINES IN VIVO

N. Weiner, P. R. Draskóczy and W. R. Burack
Journal of Pharmacology and Experimental Therapeutics July 1, 1962, 137 (1) 47-55;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE ABILITY OF TYRAMINE TO LIBERATE CATECHOLAMINES IN VIVO

N. Weiner, P. R. Draskóczy and W. R. Burack
Journal of Pharmacology and Experimental Therapeutics July 1, 1962, 137 (1) 47-55;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Reduction of 5-Hydroxytryptamine (5-HT)1A-Mediated Temperature and Neuroendocrine Responses and 5-HT1A Binding Sites in 5-HT Transporter Knockout Mice
  • Prolonged Inhibition ofO 6-Methylguanine DNA Methyltransferase in Human Tumor Cells by O 6-Benzylguanine In Vitro and In Vivo
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics